Urinary bactericidal activity of oral antibiotics against common urinary tract pathogens in an ex vivo model

Chemotherapy

Volumn 52, Issue 6, 2006, Pages 293-297

  Bedenic, Branka ^a   Topic, Marijana ^b   Budimir, Ana ^b   Bubonja, Marina ^c  

^a UNIVERSITY OF ZAGREB   (Croatia)

^b KBC Zagreb   (Croatia)

^c UNIVERSITY OF RIJEKA   (Croatia)

Author keywords

Lactam antibiotics; Bactericidal activity, urinary; Fluoroquinolones; Linezolid

Indexed keywords

AMOXICILLIN; AMOXICILLIN PLUS CLAVULANIC ACID; ANTIBIOTIC AGENT; BETA LACTAMASE; CEFADROXIL; CEFALEXIN; CEFTIBUTEN; CEFUROXIME; CIPROFLOXACIN; CIPROMED; COTRIMOXAZOLE; KLAVOCIN; LINEZOLID; NOLICIN; NORFLOXACIN; NOVOCEF; SINERSUL;

ADULT; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL STRAIN; BACTERICIDAL ACTIVITY; CONTROLLED STUDY; CROATIA; DRUG URINE LEVEL; ESCHERICHIA COLI; EX VIVO STUDY; FEMALE; GRAM NEGATIVE BACTERIUM; HUMAN; HUMAN EXPERIMENT; PATHOGENESIS; PREDICTION; PRIORITY JOURNAL; PROTEUS MIRABILIS; STAPHYLOCOCCUS SAPROPHYTICUS; URINALYSIS; URINARY TRACT; URINARY TRACT INFECTION;

ACETAMIDES; ADMINISTRATION, ORAL; ADULT; AMOXICILLIN; AMOXICILLIN-POTASSIUM CLAVULANATE COMBINATION; ANTI-BACTERIAL AGENTS; ANTI-INFECTIVE AGENTS, URINARY; BETA-LACTAMASES; BIOLOGICAL MARKERS; CEFADROXIL; CEFUROXIME; CEPHALEXIN; CEPHALOSPORINS; CIPROFLOXACIN; DISK DIFFUSION ANTIMICROBIAL TESTS; FEMALE; GRAM-NEGATIVE BACTERIA; GRAM-NEGATIVE BACTERIAL INFECTIONS; GRAM-POSITIVE BACTERIA; GRAM-POSITIVE BACTERIAL INFECTIONS; HUMANS; MIDDLE AGED; NORFLOXACIN; OXAZOLIDINONES; TIME FACTORS; TRIMETHOPRIM-SULFAMETHOXAZOLE COMBINATION; URINARY TRACT INFECTIONS;

EID: 33750259319     PISSN: 00093157     EISSN: None     Source Type: Journal    
DOI: 10.1159/000095969     Document Type: Article

References (10)

1. Ronald AR, Nicolle LE, Stamm E, Krieger J, Warren J, Schaeffer A, Naber KG, Hooton TM, Johnson J, Chambers S, Andriole V: Urinary tract infection in adults: research priorities and strategies. Int J Antimicrob Agents 2001;17:343-348.
2. Naber KG: Antibacterial activity of antibacterial agents in urine: an overview of applied methods; in Bergan T (ed): Urinary Tract Infections. Infectology. Basel, Karger, 1997, vol 1, pp 74-83.
3. Naber CK, Hammer M, Kinzig-Schippers M, Sauber C, Sorgel F, Bygate A, Fairless AJ, Machka K, Naber KG: Urinary excretion and bactericidal activities of gemifloxacin and ofloxacin after a single oral dose in healthy volunteers. Antimicrob Agents Chemother 2001;45:3524-3530.
4. Wagenlehner FME, Wydra S, Onda H, Kinzig-Schippers M, Sorgel F, Naber KG: Concentrations in plasma, urinary excretion, and bactericidal activity of linezolid (600 mg) versus those of ciprofloxacin (500 mg) in healthy volunteers receiving a single oral dose. Antimicrob Agents Chemother 2003;47:3789-3794.
5. National Committee for Clinical Laboratory Standards. Performance Standards for Antimicrobial Disk Susceptibility Tests. Approved standard M2-A5. Villanova, NCCLS, 1993.
6. National Committee for Clinical Laboratory Standards (NCCLS): Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria That Grow Aerobically. Approved standard, ed 5. NCCLS document M7-A5. Wayne, NCCLS, 2000, pp 1-25.
7. Wise R, Andrews JM: Bactericidal activity of gatifloxacin in plasma and urine. Clin Microbiol Infect 1998;4:392-396.
8. Johnson JR, Stamm WE: Overview of therapy of acute urinary tract infections; in Brumfitt W, Hamilton-Miller JMT, Bailey RR (eds): Urinary Tract Infections. London, Chapman & Hall, 1998, pp 251-264.
9. Buyukbaba-Boral O, Gonullu N, Kucukbasmaci O, Ang-Luciler, Ang O: The influence of urine on the in vitro antimicrobial activity of various antibiotics against different Escherichia coli phenotypes. Chemotherapy 2004;50:35-39.
10. Zhanel GG, Karlowsky JA, Davidson RJ, Hoban DJ: Influence of human urine on the in vitro activity and postantibiotic effect of ciprofloxacin against Escherichia coli. Chemotherapy 1991;37:218-223.